MSLE

Satellos Bioscience Inc. - Common Stock (MSLE)

About Satellos Bioscience Inc. - Common Stock (MSLE)

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Details

Daily high

$8.86

Daily low

$8.54

Price at open

$8.78

52 Week High

$13.39

52 Week Low

$5.30

Market cap

184.8M

Dividend yield

Volume

37,198

Avg. volume

31,013

P/E ratio

-4.39

Satellos Bioscience Inc. - Common Stock News